U.S. court upholds patent for Novartis MS drug Gilenya
ZURICH, Aug 17 (Reuters) - A U.S. district court upheld the validity of the dosage regimen patent for Swiss drugmaker Novartis' top-selling multiple...
ZURICH, Aug 17 (Reuters) - A U.S. district court upheld the validity of the dosage regimen patent for Swiss drugmaker Novartis' top-selling multiple...